Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469579) titled 'ALPs Single ChambEr New Device Study' on March 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Cairdac SA
Condition:
Brady-tachy Syndrome
Brady Arrythmia
Bradycardia
AV Block
Atrial Fibrillation (Paroxysmal)
Intervention:
Device: Leadless ventricular pacemaker implantation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 2026
Target Sample Size: 15
To know more, visit https://clinicaltrials.gov/study/NCT07469579
Published by HT Digital Content ...